Palvella Therapeutics, Inc.

PVLA·NASDAQ·$117.59Share Price as of 11/2·$1BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/04/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/31/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report10/28/26 8-KCurrent report08/04/26 8-KCurrent report07/14/26 8-KCurrent report06/30/26 8-KCurrent report06/16/26

Prospectuses and Registrations

S-8Registration of securities for employees08/04/26 424B5Prospectus supplement02/26/26 424B5Prospectus supplement02/24/26 S-3Shelf registration01/02/26 S-8Registration of securities for employees02/18/25

Proxies

DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 DEF 14ADefinitive proxy04/30/25 DEFA14AAdditional proxy materials04/30/25 DEF 14ADefinitive proxy11/06/24

Ownership

SC 13G/ABeneficial ownership (amended)10/28/26 Form 4Insider transaction10/23/26 144Proposed sale of securities10/21/26 Form 4Insider transaction10/14/26 144Proposed sale of securities10/13/26

Other

ARSAnnual report to shareholders04/30/26 EFFECTRequest for effectiveness01/29/26 CORRESPCorrespondence with the SEC01/27/26 UPLOADLetter from the SEC01/05/26 ARSAnnual report to shareholders04/30/25